The information is provided to you in confidence which is requested under an agreed upon and signed Confidentiality and Disclosure Agreement. Do not give this do cument or any copy of it or reveal any proprietary information contained in it to any third party (other than those in your organization who are assisting you in this work and are bound by the Confidentiality and Disclosure Agreement) without the prior wri tten permission of an authorized representative of IMDZ . 05FPRF Immune Design C orp. IMDZ -04-1702 SAP Draft V1.0 for Protocol V2.0 Version Date: 2018- 05-25 Confidential 2 / 36 SIGNATURES The undersigned have approved this Statistical Analysis Plan for use in this study. ______________________________ ____________________________ Name (Date) _____________________________ _____________________________ Name (Date) _____________________________ _____________________________ Name (Date) _____________________________ _________________________ ____ Name (Date) TABLE OF CONTENTS 05FPRF Immune Design C orp. IMDZ -04-1702 SAP Draft V1.0 for Protocol V2.0 Version Date: 2018- 05-25 Confidential 3 / 36 LIST OF ABBREVIATIONS ......................................................................................................... 6 1 INTRODUCTION ..................................................................................................................